AMBIRIX Suspension for injection Ref.[49680] Active ingredients: Hepatitis A, inactivated vaccine Hepatitis B, purified antigen

Source: Medicines & Healthcare Products Regulatory Agency (GB)  Revision Year: 2021  Publisher: GlaxoSmithKline UK Limited, 980 Great West Road, Brentford, Middlesex, TW8 9GS, United Kingdom

Product name and form

Ambirix, suspension for injection in pre-filled syringe.

Hepatitis A (inactivated) and hepatitis B (rDNA) (HAB) vaccine (adsorbed).

Pharmaceutical Form

Suspension for injection.

Ambirix is a turbid white suspension.

Qualitative and quantitative composition

1 dose (1 ml) contains:

Hepatitis A virus (inactivated)1,2 720 ELISA Units.

Hepatitis B surface antigen3,4 20 micrograms.

1 Produced on human diploid (MRC-5) cells
2 Adsorbed on aluminium hydroxide, hydrated 0.05 milligrams Al3+
3 Produced in yeast cells (Saccharomyces cerevisiae) by recombinant DNA technology
4 Adsorbed on aluminium phosphate 0.4 milligrams Al3+

For the full list of excipients, see section 6.1.

Active Ingredient Description
Hepatitis A, inactivated vaccine

Inactivated virus of a strain which was originally derived by further serial passage of a proven attenuated strain. The virus is grown, harvested, highly purified, formalin inactivated, and then adsorbed onto amorphous aluminum hydroxyphosphate sulphate.

Hepatitis B, purified antigen

Hepatitis B vaccine induces specific humoral antibodies against hepatitis B virus surface antigen (anti-HBsAg). Hepatitis B vaccine has been recognized as the first anti-cancer vaccine because it can prevent primary liver cancer.

List of Excipients

Sodium chloride
Water for injections

For adjuvants, see section 2.

Pack sizes and marketing

1 ml of suspension in a pre-filled syringe (type I glass) with a plunger stopper (rubber butyl).

Pack sizes of 1 and 10 pre-filled syringes with or without needles and pack size of 50 pre-filled syringes without needles.

Not all pack sizes may be marketed.

Marketing authorization holder

GlaxoSmithKline UK Limited, 980 Great West Road, Brentford, Middlesex, TW8 9GS, United Kingdom

Marketing authorization dates and numbers

PLGB 19494/0259

Date of first authorisation: 01/01/2021

Drugs

Drug Countries
AMBIRIX Austria, Estonia, Croatia, Ireland, Lithuania, Netherlands, Poland, United Kingdom

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.